Skip to primary navigation Skip to main content
0 item $0.00

  1. Abbas AE, Franey LM, Marwick T, Maeder MT, Kaye DM, Vlahos AP, Serra W, Al-Azizi K, Schiller NB, Lester SJ. Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr 2013;26(10):1170-7.
  2. Abbott AL, Adelman MA, Alexandrov AV, Barber PA, Barnett HJ, Beard J, Bell P, Björck M, Blacker D, Bonati LH, Brown MM, Buckley CJ, Cambria RP, Castaldo JE, Comerota AJ, Connolly ES Jr, Dalman RL, Davies AH, Eckstein HH, Faruqi R, Feasby TE, Fraedrich G, Gloviczki P, Hankey GJ, Harbaugh RE, Heldenberg E, Hennerici MG, Hill MD, Kleinig TJ, Mikhailidis DP, Moore WS, Naylor R, Nicolaides A, Paraskevas KI, Pelz DM, Prichard JW, Purdie G, Ricco JB, Ringleb PA, Riles T, Rothwell PM, Sandercock P, Sillesen H, Spence JD, Spinelli F, Sturm J, Tan A, Thapar A, Veith FJ, Wijeratne T, Zhou W. Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement. Stroke 2013;44(4):1186-90. International, multispecialty, expert review and position statement.
  3. Abegaz B, Davern PJ, Jackson KL, Nguyen-Huu TP, Bassi JK, Connelly A, Choong YT, Allen AM, Head GA. Cardiovascular role of angiotensin type1A receptors in the nucleus of the solitary tract of mice. Cardiovasc Res 2013;100(2):181-91.
  4. Alberti KG, Zimmet P. Epidemiology: global burden of disease-where does diabetes mellitus fit in? Nat Rev Endocrinol 2013;9(5):258-60. Review.
  5. Alexander K, Bryant W, Cohen N, Craig M, Forbes M, Fulcher G, Greenaway T, Harrison N, Holmes‐Walker J, Howard G, Jackson J, Jenkins A, Kamp M, Kaplan L, Kaye J, Sinha A, Stranks S, O'Neal D, Colman P; Australian National Adult Insulin Pump Therapy Working Group. Provision of quality care for adults with type 1 diabetes requiring insulin pump therapy (IPT). Infusystems Asia 2013;8(1):1-6. Guidelines.
  6. Aliprandi-Costa B, Ranasinghe I, Turnbull F, Brown A, Kritharides L, Patel A, Chew D, Walters D, Rankin J, Ilton M, Meredith I, Cass A, Brieger D. The design and rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE). Heart Lung Circ 2013;22(7):533-41.
  7. Altamore TM, Nguyen OTK, Churches QI, Cavanagh K, Nguyen XTT, Duggan SAM, Krippner GY, Duggan PJ. Concise synthesis of enantiomerically pure (1′S,2′R)-and (1′R,2′S)-2S-amino-3-(2′-aminomethyl-cyclopropyl)propionic acid: two E-diastereoisomers of 4,5-methano-L-lysine. Aust J Chem 2013;66(9):1105-11.
  8. Altenburg TM, Rotteveel J, Dunstan DW, Salmon J, Chinapaw MJ. The effect of interrupting prolonged sitting time with short hourly moderate-intensity cycling bouts on cardiometabolic risk factors in healthy young adults. J Appl Physiol 2013;115(12):1751-6.
  9. Andersen MK, Härkönen T, Forsblom C, Groop PH, Knip M, Tuomi T. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes. Autoimmunity 2013;46(4):251-8.
  10. Antony N, Weir JR, McDougall ARA, Mantamadiotis T, Meikle PJ, Cole TJ, Bird AD. cAMP response element binding protein1 is essential for activation of steroyl co-enzyme A desaturase 1 (Scd1) in mouse lung type II epithelial cells. PLoS One 2013;8(4):e59763.
  11. Artuso S, Cargo M, Brown A, Daniel M. Factors influencing health care utilisation among Aboriginal cardiac patients in central Australia: a qualitative study. BMC Health Serv Res 2013;13:83.
  12. Asferg CL, Nielsen SJ, Andersen UB, Linneberg A, Møller DV, Hedley PL, Christiansen M, Goetze JP, Esler M, Jeppesen JL. Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men. Hypertension 2013;62(1):147-53.
  13. Backholer K, Peeters A. The impact of trans fat regulation on social inequalities in coronary heart disease in Australia. Med J Aust 2013;199(3):168. Letter.
  14. Backholer K, Peeters A, Herman WH, Shaw JE, Liew D, Ademi Z, Magliano DJ. Diabetes prevention and treatment strategies: are we doing enough? Diabetes Care 2013;36(9):2714-9.
  15. Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 2013;167(5):1807-24. Systematic review.
  16. Ball J, Carrington MJ, Stewart S; on behalf of the SAFETY investigators. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart 2013;99(8):542-7.
  17. Ball J, Carrington MJ, Stewart S; on behalf of the SAFETY investigators. Reply: diagnosing vascular mild cognitive impairment with atrial fibrillation remains a challenge. Heart 2013;99(11):819-20. Author reply.
  18. Ball J, Carrington MJ, Wood KA, Stewart S; SAFETY Investigators. Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). PLoS One 2013;8(5):e65795.
  19. Bayles R, Baker EK, Jowett JB, Barton D, Esler M, El-Osta A, Lambert G. Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One 2013;8(12):e83223.
  20. Begg LM, Palma-Dias R, Wang J, Chin-Dusting JP, Skilton MR. Maternal adiposity and newborn vascular health. Arch Dis Child Fetal Neonatal Ed 2013;98(3):F279-80. Letter.
  21. Blessing E, Esler MD, Francis DP, Schmieder RE. Cardiac ablation and renal denervation systems have distinct purposes and different technical requirements. JACC Cardiovasc Interv 2013;6(3):314. Letter.
  22. Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump LC, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G. Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. EuroIntervention 2013;9(4):484-92. Protocol.
  23. Bonham MP, Linderborg KM, Dordevic A, Larsen AE, Nguo K, Weir JM, Gran P, Luotonen MK, Meikle PJ, Cameron-Smith D, Kallio HP, Sinclair AJ. Lipidomic profiling of chylomicron triacylglycerols in response to high fat meals. Lipids 2013;48(1):39-50.
  24. Boon J, Hoy AJ, Stark R, Brown RD, Meex RC, Henstridge DC, Schenk S, Meikle PJ, Horowitz JF, Kingwell BA, Bruce CR, Watt MJ. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 2013;62(2):401-10.
  25. Boslem E, Weir JM, MacIntosh G, Sue N, Cantley J, Meikle PJ, Biden TJ. Alteration of endoplasmic reticulum lipid rafts contributes to lipotoxicity in pancreatic β-cells. J Biol Chem 2013;288(37):26569-82.
  26. Boyde M, Song S, Peters R, Turner C, Thompson DR, Stewart S. Pilot testing of a self-care education intervention for patients with heart failure. Eur J Cardiovasc Nurs 2013;12(1):39-46.
  27. Bray JE, Stub D, Bernard S, Smith K. Exploring gender differences and the "oestrogen effect" in an Australian out-of-hospital cardiac arrest population. Resuscitation 2013;84(7):957-63.
  28. Brown AD, Mentha R, Rowley KG, Skinner T, Davy C, O'Dea K. Depression in Aboriginal men in central Australia: adaptation of the Patient Health Questionnaire 9. BMC Psychiatry 2013;13:271.
  29. Bruce CR, Risis S, Babb JR, Yang C, Lee-Young RS, Henstridge DC, Febbraio MA. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice. Endocrinology 2013;154(1):65-76.
  30. Bukrinsky M, Orekhov A, Ditiatkovski M, Sviridov D. Cyclophilins in atherosclerosis: a new therapeutic target? Curr Pharm Des 2013;19(33):5904-8. Review.
  31. Burch ML, Getachew R, Osman N, Febbraio MA, Little PJ. Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine kinase and serine/threonine kinase receptor transactivation in vascular smooth muscle cells. J Biol Chem 2013;288(10):7410-9.
  32. Burke SL, Prior LJ, Lukoshkova EV, Lim K, Barzel B, Davern PJ, Armitage JA, Head GA. Reduced preprandial dipping accounts for rapid elevation of blood pressure and renal sympathetic nerve activity in rabbits fed a high-fat diet. Chronobiol Int 2013;30(5):726-38.
  33. Burrell LM, Risvanis J, Dean RG, Patel SK, Velkoska E, Johnston CI. Age-dependent regulation of renal vasopressin V(1A) and V(2) receptors in rats with genetic hypertension: implications for the treatment of hypertension. J Am Soc Hypertens 2013;7(1):3-13.
  34. Butterworth PA, Urquhart DM, Cicuttini FM, Menz HB, Strauss BJ, Proietto J, Dixon JB, Jones G, Landorf KB, Wluka AE. Fat mass is a predictor of incident foot pain. Obesity 2013;21(9):E495-9.
  35. Byrne MJ, Idrizi R, Power JM, Kaye DM. Percutaneous re-circulating isolated limb perfusion of gentamicin in a large animal model: targeted delivery of gentamicin to limb. Am J Transl Res 2013;5(1):47-52.
  36. Cameron AJ, Magliano DJ, Söderberg S. A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev 2013;14(1):86-94. Systematic review.
  37. Cameron J, Worrall-Carter L, Page K, Stewart S, Ski CF. Screening for mild cognitive impairment in patients with heart failure: Montreal Cognitive Assessment versus Mini Mental State Exam. Eur J Cardiovasc Nurs 2013;12(3):252-60.
  38. Cameron JD, Dart AM. Misclassification of studies in 'Brachial artery tonometry and the Popeye phenomenon'. J Hypertens 2013;31(1):208. Letter.
  39. Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H. Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes. Intern Med J 2013;43(2):137-43.
  40. Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H. The elephant in the room of hypertension treatment: author reply. Intern Med J 2013;43(9):1052-3. Author reply.
  41. Camuglia AC, Maeder MT, Starr J, Farrington C, Kaye DM. Impact of N-acetylcysteine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trial. Heart Lung Circ 2013;22(4):256-9.
  42. Carey AL, Formosa MF, Van Every B, Bertovic D, Eikelis N, Lambert GW, Kalff V, Duffy SJ, Cherk MH, Kingwell BA. Ephedrine activates brown adipose tissue in lean but not obese humans. Diabetologia 2013;56(1):147-55.
  43. Carey AL, Kingwell BA. Brown adipose tissue in humans: therapeutic potential to combat obesity. Pharmacol Ther 2013;140(1):26-33. Review.
  44. Carey AL, Siebel AL, Reddy-Luthmoodoo M, Natoli AK, D'Souza W, Meikle PJ, Sviridov D, Drew BG, Kingwell BA. Skeletal muscle insulin resistance associated with cholesterol-induced activation of macrophages is prevented by high density lipoprotein. PLoS One 2013;8(2):e56601.
  45. Carrington MJ, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Haluska B, Thompson DR, Scuffham PA, Stewart S. Navigating the fine line between benefit and risk in chronic atrial fibrillation: rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). Int J Cardiol 2013;166(2):359-65.
  46. Carrington MJ, Chan YK, Calderone A, Scuffham PA, Esterman A, Goldstein S, Stewart S; Young at Heart Investigators. A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women: the Young at Heart Study. Circ Cardiovasc Qual Outcomes 2013;6(4):379-89.
  47. Carrington MJ, Jennings GL, Stewart S. Pressure points in primary care: blood pressure and management of hypertension in 532 050 patients from 2005 to 2010. J Hypertens 2013;31(6):1265-71.
  48. Carrington MJ, Kok S, Jansen K, Stewart S. The Green, Amber, Red Delineation of Risk and Need (GARDIAN) management system: a pragmatic approach to optimizing heart health from primary prevention to chronic disease management. Eur J Cardiovasc Nurs 2013;12(4):337-45.
  49. Carson V, Ridgers ND, Howard BJ, Winkler EA, Healy GN, Owen N, Dunstan DW, Salmon J. Light-intensity physical activity and cardiometabolic biomarkers in US adolescents. PLoS One 2013;8(8):e71417.
  50. Carson V, Salmon J, Arundell L, Ridgers ND, Cerin E, Brown H, Hesketh KD, Ball K, Chinapaw M, Yildirim M, Daly RM, Dunstan DW, Crawford D. Examination of mid-intervention mediating effects on objectively assessed sedentary time among children in the Transform-Us! cluster-randomized controlled trial. Int J Behav Nutr Phys Act 2013;10(1):62.
  51. Cerin E, Conway TL, Cain KL, Kerr J, De Bourdeaudhuij I, Owen N, Reis RS, Sarmiento OL, Hinckson EA, Salvo D, Christiansen LB, Macfarlane DJ, Davey R, Mitáš J, Aguinaga-Ontoso I, Sallis JF. Sharing good NEWS across the world: developing comparable scores across 12 countries for the Neighborhood Environment Walkability Scale (NEWS). BMC Public Health 2013;13:309.
  52. Chai Z, Dai A, Tu Y, Li J, Wu T, Wang Y, Hale LJ, Koentgen F, Thomas MC, Cooper ME. Genetic deletion of cell division autoantigen 1 retards diabetes-associated renal injury. J Am Soc Nephrol 2013;24(11):1782-92.
  53. Chamberlain C, McNamara B, Williams ED, Yore D, Oldenburg B, Oats J, Eades S. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States. Diabetes Metab Res Rev 2013;29(4):241-56. Review.
  54. Chan W, White DA, Wang XY, Bai RF, Liu Y, Yu HY, Zhang YY, Fan F, Schneider HG, Duffy SJ, Taylor AJ, Du XJ, Gao W, Gao XM, Dart AM. Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc 2013;2(5):e000226.
  55. Chazova I, Schlaich MP. Improved hypertension control with the imidazoline agonist moxonidine in a multinational metabolic syndrome population: principal results of the MERSY study. Int J Hypertens 2013;2013:541689.
  56. Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J, Hagemeyer CE, Hannan RD, Bobik A, Peter K. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res 2013;113(3):252-65.
  57. Chin-Dusting J, Head G, Wright C, Elghozi JL, Friberg P, Adams MA, Courneya CA, Badoer E, Kingwell B. Paul I Korner (1925-2012). Clin Exp Pharmacol Physiol 2013;40(3):169-76. Obituary.
  58. Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K. Molecular profiling of human mammary gland links breast cancer risk to a p27+ cell population with progenitor characteristics. Cell Stem Cell 2013;13(1):117-30.
  59. Chung RW, Kamili A, Tandy S, Weir JM, Gaire R, Wong G, Meikle PJ, Cohn JS, Rye KA. Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice. PLoS One 2013;8(2):e55949.
  60. Clark BK, Winkler E, Healy GN, Gardiner PG, Dunstan DW, Owen N, Reeves MM. Adults' past-day recall of sedentary time: reliability, validity, and responsiveness. Med Sci Sports Exerc 2013;45(6):1198-1207.
  61. Cohen N. Is prevention of type 2 diabetes possible? Endocrinol Today 2013;2(3):32-4. Comment.
  62. Cohen N. Type 2 diabetes: why a timely diagnosis matters. Endocrinol Today 2013;2(1):14-6. Review.
  63. Cohen N. Insulin and GLP1 agonist - is this the new frontier in type 2 diabetes? Diabetes Manag J 2013;42:4-5. Comment.
  64. Cohen ND, Audehm R, Pretorius E, Kaye J, Chapman LH, Colagiuri S. The rationale for combining GLP-1 receptor agonists with basal insulin. Med J Aust 2013;199(4):246-9.
  65. Cohen ND, Hong ES, Van Drie C, Balkau B, Shaw J. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes. Diabetes Technol Ther 2013;15(7):544-9.
  66. Coles L, Rutherfurd S, Moughan P. A model to predict the ATP equivalents of macronutrients absorbed from food. Food Funct 2013;4(3):432-42.
  67. Cooley N, Ouyang K, McMullen JR, Kiriazis H, Sheikh F, Wu W, Mu Y, Du XJ, Chen J, Woodcock EA. No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy. Circ Heart Fail 2013;6(2):318-25.
  68. Cooper ME. Choosing the right angiotensin-receptor blocker for patients with diabetes: still controversial. CMAJ 2013;185(12):1023-4. Comment.
  69. Cowling CS, Liu BC, Ward J, Snelling TL, Kaldor JM, Wilson D. Australian trachoma surveillance annual report, 2011. Commun Dis Intell Q Rep 2013;37(2):E121-9. Commissioned report.
  70. Crammond B, Van C, Allender S, Peeters A, Lawrence M, Sacks G, Mavoa H, Swinburn BA, Loff B. The possibility of regulating for obesity prevention - understanding regulation in the Commonwealth Government. Obes Rev 2013;14(3):213-21. Review.
  71. Crul T, Toth N, Piotto S, Literati-Nagy P, Tory K, Haldimann P, Kalmar B, Greensmith L, Torok Z, Balogh G, Gombos I, Campana F, Concilio S, Gallyas F, Nagy G, Berente Z, Gungor B, Peter M, Glatz A, Hunya A, Literati-Nagy Z, Vigh L Jr, Hoogstra-Berends F, Heeres A, Kuipers I, Loen L, Seerden JP, Zhang D, Meijering RA, Henning RH, Brundel BJ, Kampinga HH, Koranyi L, Szilvassy Z, Mandl J, Sumegi B, Febbraio MA, Horvath I, Hooper PL, Vigh L. Hydroximic acid derivatives: pleiotropic HSP co-inducers restoring homeostasis and robustness. Curr Pharm Des 2013;19(3):309-46. Review.
  72. d'Abbs P, Togni S, Rosewarne C, Boffa J. The Grog Mob: lessons from an evaluation of a multi-disciplinary alcohol intervention for Aboriginal clients. Aust N Z J Public Health 2013;37(5):450-6.
  73. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Sikaris KA, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR. Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis 2013;62(1):58-66.
  74. Davern PJ, McKinley MJ. Brain regions influenced by the lateral parabrachial nucleusor angiotensin II-induced water intake. Neuroscience 2013;252:410-9.
  75. de Courten B, de Courten MP, Dougherty S, Forbes JM, Potts JR, Considine RV. Insulin infusion reduces hepatocyte growth factor in lean humans. Metabolism 2013;62(5):647-50.
  76. Dempsey AR, Wang Y, Thorlund JB, Mills PM, Wrigley TV, Bennell KL, Metcalf BR, Hanna F, Cicuttini FM, Lloyd DG. The relationship between patellofemoral and tibiofemoral morphology and gait biomechanics following arthroscopic partial medial meniscectomy. Knee Surg Sports Traumatol Arthrosc 2013;21(5):1097-103.
  77. Dhar AK, Lambert GW. Seasonal changes in blood pressure: possible interaction between sunlight and brain serotonin. Hypertension 2013;62(1):e1. Letter.
  78. Di Marco E, Gray SP, Jandeleit-Dahm K. Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature. Front Endocrinol 2013;4:68. Review.
  79. Ditiatkovski M, D'Souza W, Kesani R, Chin-Dusting J, de Haan JB, Remaley A, Sviridov D. An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice. PLoS One 2013;8(7):e68802.
  80. Dixon JB, Browne JL, Lambert GW, Jones KM, Reddy P, Pouwer F, Speight J. Severely obese people with diabetes experience impaired emotional well-being associated with socioeconomic disadvantage: results from diabetes MILES - Australia. Diabetes Res Clin Pract 2013;101(2):131-40.
  81. Dixon JB, Chuang LM, Chong K, Chen SC, Lambert GW, Straznicky NE, Lambert EA, Lee WJ. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2013;36(1):20-6.
  82. Dixon JB, Cobourn CS. Exploration of esophageal hiatus: does crural repair reduce proximal pouch distension? Surg Obes Relat Dis 2013;9(3):350-5.
  83. Dixon JB, Cobourn CS. Risk of gastric pouch enlargement with adjustable gastric banding in premenopausal women: sex hormones may play a role? Ann Surg 2013;257(3):456-61.
  84. Dixon JB, Hur KY, Lee WJ, Kim MJ, Chong K, Chen SC, Straznicky NE, Zimmet P. Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabet Med 2013;30(4):e127-34.
  85. Dixon JB, Lambert GW. The obesity paradox - a reality that requires explanation and clinical interpretation. Atherosclerosis 2013;226(1):47-8. Editorial.
  86. Dixon JB, Logue J, Komesaroff PA. Promises and ethical pitfalls of surgical innovation: the case of bariatric surgery. Obes Surg 2013;23(10):1698-702. Review.
  87. Dreyer N, Dixon JB, Okerson T, Finkelstein EA, Globe D. Prevalence of comorbidities and baseline characteristics of LAP-BAND AP® subjects in the Helping Evaluate Reduction in Obesity (HERO) study. PLoS One 2013;8(11):e78971.
  88. Driscoll A, Tonkin A, Stewart A, Worrall-Carter L, Thompson DR, Riegel B, Hare DL, Davidson PM, Mulvany C, Stewart S. Complexity of management and health outcomes in a prospective cohort study of 573 heart failure patients in Australia: does more equal less? J Clin Nurs 2013;22(11-12):1629-38.
  89. Du XJ. Findings from recent clinical studies on relaxin therapy of acute decompensated heart failure: translational implications. Chin J Front Med Sci 2013;5(10):15-20. Review.
  90. Du XJ, Kiriazis H. Pro-inflammatory role of platelets in hypertension-mediated end-organ damage: Editorial to: "Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis" by L.-X. Jia et al.. Cardiovasc Drugs Ther 2013;27(6):485-7. Editorial.
  91. Duennwald T, Gatterer H, Groop PH, Burtscher M, Bernardi L. Effects of a single bout of interval hypoxia on cardiorespiratory control and blood glucose in patients with type 2 diabetes. Diabetes Care 2013;36(8):2183-9.
  92. Dumonteil N, Vaccaro A, Despas F, Labrunee M, Marcheix B, Lambert E, Esler M, Carrie D, Senard JM, Galinier M, Pathak A. Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis. JACC Cardiovasc Interv 2013;6(11):1195-202.
  93. Dunstan DW, Wiesner G, Eakin EG, Neuhaus M, Owen N, Lamontagne AD, Moodie M, Winkler EA, Fjeldsoe BS, Lawler S, Healy GN. Reducing office workers' sitting time: rationale and study design for the Stand Up Victoria cluster randomized trial. BMC Public Health 2013;13(1):1057. Protocol.
  94. Duytschaever M, De Meyer G, Acena M, El-Haddad M, De Greef Y, Van Heuverswyn F, Vandekerckhove Y, Tavernier R, Lee G, Kistler P. Lessons from dissociated pulmonary vein potentials: entry block implies exit block. Europace 2013;15(6):805-12.
  95. Eakin EG, Reeves MM, Winkler E, Healy GN, Dunstan DW, Owen N, Marshal AM, Wilkie KC. Six-month outcomes from Living Well with Diabetes: a randomized trial of at telephone-delivered weight loss and physical activity intervention to improve glycemic control. Ann Behav Med 2013;46(2):193-203.
  96. Ellims AH, Mariani JA, Schlaich MP. Restoration of blood pressure control with pacemaker implantation in a patient with bradycardia and resistant hypertension: a case report. Int J Cardiol 2013;167(2):e38-40. Letter.
  97. Ellims AH, Pfluger H, Elsik M, Butler MJ, Hare JL, Taylor AJ. Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long-term survival following cardiac resynchronisation therapy. Int J Cardiovasc Imaging 2013;29(6):1303-11.
  98. Eppel GA, Armitage JA, Eikelis N, Head GA, Evans RG. Progression of cardiovascular and endocrine dysfunction in a rabbit model of obesity. Hypertens Res 2013;36(7):588-95.
  99. Fagherazzi G, Vilier A, Balkau B, Clavel-Chapelon F, Magliano DJ. Anthropometrics, body shape over 12 years and risk of cancer events in pre- and post-menopausal women. Int J Cancer 2013;133(3):740-8.
  100. Falkenberg C, Östman-Smith I, Gilljam T, Lambert G, Friberg P. Cardiac autonomic function in adolescents operated by arterial switch surgery. Int J Cardiol 2013;168(3):1887-93.
  101. Fang L, Beale A, Ellims AH, Moore XL, Ling LH, Taylor AJ, Chin-Dusting J, Dart AM. Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy. J Am Heart Assoc 2013;2(5):e000270.
  102. Fatima SS, Bozaoglu K, Rehman R, Alam F, Memon AS. Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes. PLoS One 2013;8(2):e57113.
  103. Fineberg D, Jandeleit-Dahm KA, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol 2013;9(12):713-23. Review.
  104. Fink K, Busch HJ, Bourgeois N, Schwarz M, Wolf D, Zirlik A, Peter K, Bode C, von Zur Muhlen C. Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation? PLoS One 2013;8(2):e53103.
  105. Finkelstein EA, Allaire BT, Globe D, Dixon JB. The business case for bariatric surgery revisited: a non-randomized case-control study. PLoS One 2013;8(9):e75498.
  106. Foley DL, Mackinnon A, Watts GF, Shaw JE, Magliano DJ, Castle DJ, McGrath JJ, Waterreus A, Morgan VA, Galletly CA. Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS One 2013;8(12):e82606.
  107. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013;93(1):137-88. Review.
  108. Forbes JM, Cowan SP, Andrikopoulos S, Morley AL, Ward LC, Walker KZ, Cooper ME, Coughlan MT. Glucose homeostasis can be differentially modulated by varying individual components of a western diet. J Nutr Biochem 2013;24(7):1251-7.
  109. Forbes JM, Ke BX, Nguyen TV, Henstridge DC, Penfold SA, Laskowski A, Sourris KC, Groschner LN, Cooper ME, Thorburn DR, Coughlan MT. Deficiency in mitochondrial complex I activity due to Ndufs6 gene trap insertion induces renal disease. Antioxid Redox Signal 2013;19(4):331-43.
  110. Franchitto N, Despas F, Labrunee M, Vaccaro A, Lambert E, Lambert G, Galinier M, Senard JM, Pathak A. Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity. Int J Cardiol 2013;168(3):2352-7.
  111. Freak-Poli R, Wolfe R, Brand M, de Courten M, Peeters A. Eight-month postprogram completion: change in risk factors for chronic disease amongst participants in a 4-month pedometer-based workplace health program. Obesity 2013;21(9):E360-8.
  112. Freak-Poli RL, Cumpston M, Peeters A, Clemes SA. Workplace pedometer interventions for increasing physical activity. Cochrane Database Syst Rev 2013;4:CD009209. Review.
  113. Fu Y, Cui HL, Sviridov D, Mukhamedova N. An internal standard for protein purification by affinity sorption. Anal Methods 2013;5:1352-4.
  114. Fu Y, Mukhamedova N, Ip S, D'Souza W, Henley KJ, Ditommaso T, Kesani R, Ditiatkovski M, Jones L, Lane RM, Jennings G, Smyth IM, Kile BT, Sviridov D. ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis. Cell Metab 2013;18(2):225-38.
  115. Gearon E, Backholer K, Hodge A, Peeters A. The mediating role of dietary factors and leisure time physical activity on socioeconomic inequalities in body mass index among Australian adults. BMC Public Health 2013;13(1):1214.
  116. George AJ, Purdue BW, Gould CM, Thomas DW, Handoko Y, Qian H, Quaife-Ryan GA, Morgan KA, Simpson KJ, Thomas WG, Hannan RD. A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation. J Cell Sci 2013;126(Pt 23):5377-90.
  117. Goode A, Reeves M, Owen N, Eakin E. Results from the dissemination of an evidence-based telephone-delivered intervention for healthy lifestyle and weight loss: the Optimal Health Program. Transl Behav Med 2013;3(4):340-50.
  118. Goodwin M, Herath C, Jia Z, Leung C, Coughlan MT, Forbes J, Angus P. Advanced glycation end products augment experimental hepatic fibrosis. J Gastroenterol Hepatol 2013;28(2):369-76.
  119. Gopee E, van den Oever EL, Cameron F, Thomas MC. Coeliac disease, gluten-free diet and the development and progression of albuminuria in children with type 1 diabetes. Pediatr Diabetes 2013;14(6):455-8.
  120. Gordin D, Kaaja R, Forsblom C, Hiilesmaa V, Teramo K, Groop PH. Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life. Acta Diabetol 2013;50(5):781-7.
  121. Gordin D, Soro-Paavonen A, Thomas MC, Harjutsalo V, Saraheimo M, Bjerre M, Forsblom C, Flyvbjerg A, Groop PH; FinnDiane Study Group. Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. Diabetes Care 2013;36(7):1827-33.
  122. Gorman E, Ashe MC, Dunstan DW, Hanson HM, Madden K, Winkler EA, McKay HA, Healy GN. Does an 'activity-permissive' workplace change office workers' sitting and activity time? PLoS One 2013;8(10):e76723.
  123. Graham S, Guy RJ, Cowie B, Wand HC, Donovan B, Akre SP, Ward JS. Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis. BMC Infect Dis 2013;13:403. Systematic review.
  124. Grantham NM, Magliano DJ, Hodge A, Jowett J, Meikle P, Shaw JE. The association between dairy food intake and the incidence of diabetes in Australia: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Public Health Nutr 2013;16(2):339-45.
  125. Grantham NM, Magliano DJ, Tanamas SK, Söderberg S, Schlaich MP, Shaw JE. Higher heart rate increases risk of diabetes among men: the Australian Diabetes Obesity and Lifestyle (AusDiab) Study. Diabet Med 2013;30(4):421-7.
  126. Gray SP, Di Marco E, Okabe J, Szyndralewiez C, Heitz F, Montezano AC, de Haan JB, Koulis C, El-Osta A, Andrews KL, Chin-Dusting JP, Touyz RM, Wingler K, Cooper ME, Schmidt HH, Jandeleit-Dahm KA. NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 2013;127(18):1888-902.
  127. Grima M, Dixon JB. Obesity - recommendations for management in general practice and beyond. Aust Fam Physician 2013;42(8):532-41. Review.
  128. Grima M, Middleton S, Dixon JB. Bariatric surgery for the treatment of severe complex obesity: an update. Nutr Diet 2013;70(3):172-4. Comment.
  129. Groop PH, Cooper ME, Perkovic V, Emser A, Woerle HJ, von Eynatten M. Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction. Diabetes Care 2013;36(11):3460-8.
  130. Gubhaju L, McNamara BJ, Banks E, Joshy G, Raphael B, Williamson A, Eades SJ. The overall health and risk factor profile of Australian Aboriginal and Torres Strait Islander participants from the 45 and up study. BMC Public Health 2013;13(1):661.
  131. Gurusinghe S, Brown RD, Cai X, Samuel CS, Ricardo SD, Thomas MC, Kett MM. Does a nephron deficit exacerbate the renal and cardiovascular effects of obesity? PLoS One 2013;8(9):e73095.
  132. Guy RJ, Natoli L, Ward J, Causer L, Hengel B, Whiley D, Tabrizi SN, Donovan B, Fairley CK, Badman SB, Tangey A, Wand H, Shephard M, Regan DG, Wilson D, Anderson D, Kaldor JM. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocol. BMC Infect Dis 2013;13:485. Protocol.
  133. Hägg S, Thorn LM, Putaala J, Liebkind R, Harjutsalo V, Forsblom CM, Gordin D, Tatlisumak T, Groop PH; FinnDiane Study Group. Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care 2013;36(12):4140-6.
  134. Hare JL, Sharman JE, Leano R, Jenkins C, Wright L, Marwick TH. Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise. Am J Hypertens 2013;26(5):691-9.
  135. Hare MJ, Magliano DJ, Zimmet PZ, Söderberg S, Joonas N, Pauvaday V, Larhubarbe J, Tuomilehto J, Kowlessur S, Alberti KG, Shaw JE. Glucose-independent ethnic differences in HbA1c in people without known diabetes. Diabetes Care 2013;36(6):1534-40.
  136. Harrois A, Baudry N, Huet O, Kato H, Lohez M, Ziol M, Duranteau J, Vicaut E. Synergistic deleterious effect of hypoxemia and hypovolemia on microcirculation in intestinal villi. Crit Care Med 2013;41(11):e376-84.
  137. Hawkes AL, Chambers SK, Pakenham KI, Patrao TA, Baade PD, Lynch BM, Aitken JF, Meng X, Courneya KS. Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J Clin Oncol 2013;31(18):2313-21.
  138. Head GA, McGrath BP, Nelson MR, Stowasser M. Importance of ambulatory blood pressure in hypertension management. Med J Aust 2013;198(1):26. Author reply.
  139. Healy GN, Eakin EG, Lamontagne AD, Owen N, Winkler EA, Wiesner G, Gunning L, Neuhaus M, Lawler S, Fjeldsoe BS, Dunstan DW. Reducing sitting time in office workers: short-term efficacy of a multicomponent intervention. Prev Med 2013;57(1):43-8.
  140. Heck PM, Lee JM, Kistler PM. Atrial fibrillation in heart failure in the older population. Heart Fail Clin 2013;9(4):451-9. Review.
  141. Heilbronn LK, Coster AC, Campbell LV, Greenfield JR, Lange K, Christopher MJ, Meikle PJ, Samocha-Bonet D. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity 2013;21(12):E649-59.
  142. Hering D, Esler MD, Schlaich MP. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation. EuroIntervention 2013;9 Suppl R:R127-35. Review.
  143. Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP. Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens 2013;31(9):1893-900.
  144. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013;61(2):457-64.
  145. Hietala K, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Higher age at onset of type 1 diabetes increases risk of macular oedema. Acta Ophthalmol 2013;91(8):709-15.
  146. Hietala K, Wadén J, Forsblom C, Harjutsalo V, Kytö J, Summanen P, Groop PH; FinnDiane Study Group. HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes. Diabetologia 2013;56(4):737-45.
  147. Hodgson JM, Croft KD, Woodman RJ, Puddey IB, Fuchs D, Draijer R, Lukoshkova E, Head GA. Black tea lowers the rate of blood pressure variation: a randomized controlled trial. Am J Clin Nutr 2013;97(5):943-50.
  148. Hodgson JM, Head GA. Reply to ML Zwinkels et al. Am J Clin Nutr 2013;98(3):857-8. Author reply.
  149. Hodsman P, Ashman C, Cahn A, De Boever E, Locantore N, Serone A, Pouliquen I. A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics. Br J Clin Pharmacol 2013;75(1):118-28.
  150. Hohmann JD, Wang X, Krajewski S, Selan C, Haller CA, Straub A, Chaikof EL, Nandurkar HH, Hagemeyer CE, Peter K. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding? Blood 2013;121(16):3067-75.
  151. Howard BJ, Fraser SF, Sethi P, Cerin E, Hamilton MT, Owen N, Dunstan DW, Kingwell BA. Impact on hemostatic parameters of interrupting sitting with intermittent activity. Med Sci Sports Exerc 2013;45(7):1285-91.
  152. Htun NM, Peter K. Coagulation disorders and aortic stenosis: a chicken and egg question? J Thromb Haemost 2013;11(4):731-2. Comment.
  153. Hu M, Crawford SA, Henstridge DC, Ng IH, Boey EJ, Xu Y, Febbraio MA, Jans DA, Bogoyevitch MA. p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival. Biochem J 2013;453(3):381-91.
  154. Huet O, Laemmel E, Fu Y, Dupic L, Aprico A, Andrews KL, Moore SL, Harrois A, Meikle PL, Vicaut E, Chin-Dusting JP, Duranteau J. Interleukin 10 antioxidant effect decreases leukocytes/endothelial interaction induced by tumor necrosis factor α. Shock 2013;39(1):83-9.
  155. Huet O, Ramsey D, Miljavec S, Jenney A, Aubron C, Aprico A, Stefanovic N, Balkau B, Head GA, de Haan JB, Chin-Dusting JP. Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock. Shock 2013;39(6):488-94.
  156. Hui BB, Gray RT, Wilson DP, Ward JS, Smith AM, Philp DJ, Law MG, Hocking JS, Regan DG. Population movement can sustain STI prevalence in remote Australian indigenous communities. BMC Infect Dis 2013;13:188.
  157. Hui BB, Wilson DP, Ward JS, Guy RJ, Kaldor JM, Law MG, Hocking JS, Regan DG. The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence. Sex Health 2013;10(4):348-56.
  158. Hung J, Teng TH, Finn J, Knuiman M, Briffa T, Stewart S, Sanfilippo FM, Ridout S, Hobbs M. Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia. J Am Heart Assoc 2013;2(5):e000172.
  159. Hurune PN, O'Shea JM, Maguire GP, Hewagama SS. Utility of exercise electrocardiography testing for the diagnosis of coronary artery disease in a remote Australian setting. Med J Aust 2013;199(3):201-4.
  160. Huynh K, Kiriazis H, Du XJ, Love JE, Gray SP, Jandeleit-Dahm KA, McMullen JR, Ritchie RH. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radic Biol Med 2013;60:307-17.
  161. Hyvönen ME, Ihalmo P, Sandholm N, Stavarachi M, Forsblom C, McKnight AJ, Lajer M, Maestroni A, Lewis G, Tarnow L, Maestroni S, Zerbini G, Parving HH, Maxwell AP, Groop PH, Lehtonen S. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes. Acta Diabetol 2013;50(6):887-97.
  162. Iles LM, Taylor AJ. Letter by Iles and Taylor regarding article, "Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume". Circ Cardiovasc Imaging 2013;6(4):e25. Letter.
  163. Iles LM, Taylor AJ. Is one better than two?: T1 mapping in myocarditis. JACC Cardiovasc Imaging 2013;6(10):1059-61. Editorial.
  164. Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD, Hou YR, Pitt B, Dargie HJ, Ford I, Kjekshus J, Zannad F, Dickstein K, McMurray JJ. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. Int J Cardiol 2013;168(2):1094-101.
  165. Inglis SC, Lewsey JD, Lowe GD, Jhund P, Gillies M, Stewart S, Capewell S, Macintyre K, McMurray JJ. Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: Impact on general and mental health, quality of life and five-year mortality. Int J Cardiol 2013;167(5):2149-55.
  166. Inoue S, Sugiyama T, Takamiya T, Oka K, Owen N, Shimomitsu T. Television viewing time is associated with overweight/obesity among older adults, independent of meeting physical activity and health guidelines: reply to Stabler and colleagues. J Epidemiol 2013;23(5):398. Author reply.
  167. Irvine JC, Cao N, Gossain S, Alexander AE, Love JE, Qin C, Horowitz JD, Kemp-Harper BK, Ritchie RH. HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO. Am J Physiol Heart Circ Physiol 2013;305(3):H365-77.
  168. Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC; Collaborative Study Group. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers. Nephrology 2013;18(7):516-24.
  169. Iyngkaran P, Anavekar N, Majoni W, Thomas MC. The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes. Diabetes Metab 2013;39(4):290-8. Review.
  170. Jackson KL, Marques FZ, Watson AM, Palma-Rigo K, Nguyen-Huu TP, Morris BJ, Charchar FJ, Davern PJ, Head GA. A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice. Hypertension 2013;62(4):775-81.
  171. Jancovski N, Bassi JK, Carter DA, Choong YT, Connelly A, Nguyen TP, Chen D, Lukoshkova EV, Menuet C, Head GA, Allen AM. Stimulation of angiotensin type 1A receptors on catecholaminergic cells contributes to angiotensin-dependent hypertension. Hypertension 2013;62(5):866-71.
  172. Jandeleit-Dahm KA, Schmidt HH. Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance-Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130-2134. Diabetes 2013;62(12):e30. Letter.
  173. Jaworski C, Looi JL, Martin J, Bergin P, Hare J, Kaye D, Wei A, Taylor AJ. Cardiac imaging in FIP1L1-PDGFRA. J Am Coll Cardiol 2013;62(14):1304. Image.
  174. Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol 2013;61(23):2319-28. Review.
  175. Jennings GL. Recent clinical trials of hypertension management. Hypertension 2013;62(1):3-7. Review.
  176. Jennings GL, Touyz RM. Hypertension guidelines: more challenges highlighted by Europe. Hypertension 2013;62(4):660-5. Review.
  177. Jennings GL, Walsh MK. Integrated health research centres for Australia. Med J Aust 2013;199(5):320-1. Review.
  178. Johnston CL, Maxwell LJ, Boyle E, Maguire GP, Alison JA. Improving chronic lung disease management in rural and remote Australia: the Breathe Easy Walk Easy programme. Respirology 2013;18(1):161-9.
  179. Jones LV, Jones KM, Hensman C, Bertuch R, McGee TL, Dixon JB. Solid versus liquid - satiety study in well-adjusted lap-band patients. Obes Surg 2013;23(8):1266-72.
  180. Joshi MS, Berger PJ, Kaye DM, Pearson JT, Bauer JA, Ritchie RH. Functional relevance of genetic variations of endothelial nitric oxide synthase and vascular endothelial growth factor in diabetic coronary microvessel dysfunction. Clin Exp Pharmacol Physiol 2013;40(4):253-61. Review.
  181. Kapellas K, Do LG, Bartold PM, Skilton MR, Maple-Brown LJ, O'Dea K, Brown A, Celermajer DS, Slade GD, Jamieson LM. Effects of full-mouth scaling on the periodontal health of Indigenous Australians: a randomized controlled trial. J Clin Periodontol 2013 40(11) 1016-24.
  182. Kaye DM, Khammy O, Mariani J, Maeder MT. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure. Eur J Heart Fail 2013;15(3):292-8.
  183. Keating C, Dawood T, Barton DA, Lambert GW, Tilbrook AJ. Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder. BMC Psychiatry 2013;13:124.
  184. Keating CL, Peeters A, Swinburn BA, Carter R, Moodie ML. Pharmaceutical utilisation and costs before and after bariatric surgery. Int J Obes 2013;37(11):1467-72.
  185. Keating CL, Peeters A, Swinburn BA, Magliano DJ, Moodie ML. Utility-based quality of life associated with overweight and obesity: the Australian Diabetes, Obesity, and Lifestyle Study. Obesity 2013;21(3):652-5.
  186. Keating S, El-Osta A. Transcriptional regulation by the Set7 lysine methyltransferase. Epigenetics 2013;8(4):361-72. Review.
  187. Keating S, El-Osta A. Epigenetic changes in diabetes. Clin Genet 2013;84(1):1-10. Review.
  188. Keating ST, El-Osta A. Glycemic memories and the epigenetic component of diabetic nephropathy. Curr Diab Rep 2013;13(4):574-81. Review.
  189. Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire G, Kelly PM, Anstey NM, Ralph AP. Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between Papuan and non-Papuan ethnic groups. PLoS One 2013;8(9):e76077.
  190. Kerr J, Sallis JF, Owen N, De Bourdeaudhuij I, Cerin E, Sugiyama T, Reis R, Sarmiento O, Frömel K, Mitás J, Troelsen J, Christiansen LB, Macfarlane D, Salvo D, Schofield G, Badland H, Guillen-Grima F, Aguinaga-Ontoso I, Davey R, Bauman A, Saelens B, Riddoch C, Ainsworth B, Pratt M, Schmidt T, Frank L, Adams M, Conway T, Cain K, Van Dyck D, Bracy N. Advancing science and policy through a coordinated international study of physical activity and built environments: IPEN adult methods. J Phys Act Health 2013;10(4):581-601. Protocol.
  191. Kikuchi H, Inoue S, Sugiyama T, Owen N, Oka K, Shimomitsu T. Correlates of prolonged television viewing time in older Japanese men and women. BMC Public Health 2013;13:213.
  192. Kilov G, Leow S, Thomas M. SGLT2 inhibition with dapagliflozin: a novel approach for the management of type 2 diabetes. Aust Fam Physician 2013;42(10):706-10. Review.
  193. Kingwell BA, Chapman MJ. Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease. Circulation 2013;128(10):1112-21. Review.
  194. Kiriazis H, Tugiono N, Xu Q, Gao XM, Jennings NL, Ming Z, Su Y, Klenowski P, Summers RJ, Kaumann A, Molenaar P, Du XJ. Chronic activation of the low affinity site of β1 -adrenoceptors stimulates haemodynamics but exacerbated pressure-overload cardiac remodelling. Br J Pharmacol 2013;170(2):352-65.
  195. Kistler PM. Focal atrial tachycardia. UpToDate 2013. Guidelines.
  196. Kitamura H, Kimura S, Shimamoto Y, Okabe J, Ito M, Miyamoto T, Naoe Y, Kikuguchi C, Meek B, Toda C, Okamoto S, Kanehira K, Hase K, Watarai H, Ishizuka M, El-Osta A, Ohara O, Miyoshi I. Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammation. FASEB J 2013;27(12):4940-53.
  197. Klein KM, Bromhead CJ, Smith KR, O'Callaghan CJ, Corcoran SJ, Heron SE, Iona X, Hodgson BL, McMahon JM, Lawrence KM, Scheffer IE, Dibbens LM, Bahlo M, Berkovic SF. Autosomal dominant vasovagal syncope: clinical features and linkage to chromosome 15q26. Neurology 2013;80(16):1485-93.
  198. Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care 2013;36(4):914-21.
  199. Kobow K, El-Osta A, Blümcke I. The methylation hypothesis of pharmacoresistance in epilepsy. Epilepsia 2013;54 Suppl 2:41-7. Review.
  200. Kobow K, Kaspi A, Harikrishnan KN, Kiese K, Ziemann M, Khurana I, Fritzsche I, Hauke J, Hahnen E, Coras R, Mühlebner A, El-Osta A, Blümcke I. Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 2013;126(5):741-56.
  201. Koohsari MJ, Badland H, Giles-Corti B. (Re)Designing the built environment to support physical activity: bringing public health back into urban design and planning. Cities 2013;35:294-8. Comment.
  202. Koohsari MJ, Kaczynski AT, Giles-Corti B, Karakiewicz JA. Effects of access to public open spaces on walking: is proximity enough? Landscape Urban Plan 2013;117:92-9.
  203. Korja M, Thorn LM, Hägg S, Putaala J, Liebkind R, Harjutsalo V, Forsblom CM, Gordin D, Tatlisumak T, Groop PH; FinnDiane Study Group. Subarachnoid hemorrhage in type 1 diabetes: a prospective cohort study of 4,083 patients with diabetes. Diabetes Care 2013;36(11):3754-8.
  204. Kowalski GM, Carey AL, Selathurai A, Kingwell BA, Bruce CR. Plasma sphingosine-1-phosphate is elevated in obesity. PLoS One 2013;8(9):e72449.
  205. Kraakman MJ, Allen TL, Whitham M, Iliades P, Kammoun HL, Estevez E, Lancaster GI, Febbraio MA. Targeting gp130 to prevent inflammation and promote insulin action. Diabetes Obes Metab 2013;15 Suppl 3:170-5. Review.
  206. Krum H, Forbes A, Yallop J, Driscoll A, Croucher J, Chan B, Clark R, Davidson P, Huynh L, Kasper EK, Hunt D, Egan H, Stewart S, Piterman L, Tonkin A. Telephone support to rural and remote patients with heart failure: the Chronic Heart Failure Assessment by Telephone (CHAT) study. Cardiovasc Ther 2013;31(4):230-7.
  207. Krum H, Schlaich M, Sobotka P. Renal sympathetic nerve ablation for treatment-resistant hypertension. Br J Clin Pharmacol 2013;76(4):495-503. Review.
  208. Kulkarni H, Meikle PJ, Mamtani M, Weir JM, Barlow CK, Jowett JB, Bellis C, Dyer TD, Johnson MP, Rainwater DL, Almasy L, Mahaney MC, Comuzzie AG, Blangero J, Curran JE. Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols. Hypertension 2013;62(3):621-6.
  209. Kulkarni H, Meikle PJ, Mamtani M, Weir JM, Barlow CK, Jowett JB, Bellis C, Dyer TD, Johnson MP, Rainwater DL, Almasy L, Mahaney MC, Comuzzie AG, Blangero J, Curran JE. Variability in associations of phosphatidylcholine molecular species with metabolic syndrome in Mexican-American families. Lipids 2013;48(5):497-503.
  210. Kumar S, Haqqani HM, Chan M, Lee J, Yudi M, Wong MC, Morton JB, Ling LH, Robinson T, Heck PM, Kelland NF, Halloran K, Spence SJ, Kistler PM, Kalman JM. Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans. Heart Rhythm 2013;10(7):962-9.
  211. Kumar S, Walters TE, Halloran K, Morton JB, Hepworth G, Wong CX, Kistler PM, Sanders P, Kalman JM. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia. Europace 2013;15(12):1702-9.
  212. Kuruppu S, Rajapakse NW, Smith AI. Endothelin-converting enzyme-1 inhibition and renoprotection in end-stage renal disease. Pflugers Arch 2013;465(7):929-34. Review.
  213. Kyaw T, Cui P, Tay C, Kanellakis P, Hosseini H, Liu E, Rolink AG, Tipping P, Bobik A, Toh BH. BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice. PLoS One 2013;8(4):e60430.
  214. Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A, Li P, Tipping P, Bobik A, Toh BH. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in ApoE-deficient mice. Circulation 2013;127(9):1028-39.
  215. Lambert E, d'Udekem Y, Cheung M, Sari CI, Inman J, Ahimastos A, Eikelis N, Pathak A, King I, Grigg L, Schlaich M, Lambert G. Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol 2013;167(4):1333-8.
  216. Lambert E, Straznicky N, Sari CI, Eikelis N, Hering D, Head G, Dixon J, Esler M, Schlaich M, Lambert G. Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 2013;26(2):250-6.
  217. Lambert EA, Straznicky NE, Lambert GW. A sympathetic view of human obesity. Clin Auton Res 2013;23(1):9-14. Review.
  218. Lambert GW. Comment on: Effects of surgically-induced weight loss via Roux-en-Y gastric bypass on cardiovascular autonomic nerve function. Surg Obes Relat Dis 2013;9(2):226-8. Comment.
  219. Lambert GW, Dhar AK, Schlaich MP. Cognitive performance in patients with resistant hypertension following renal sympathetic denervation. EuroIntervention 2013;9(6):665-7. Editorial.
  220. Lambert GW, Hering D, Esler MD, Marusic P, Lambert EA, Tanamas SK, Shaw J, Krum H, Dixon JB, Barton DA, Schlaich MP. Response to quality of life after renal denervation. Hypertension 2013;61(4):e39. Author reply.
  221. Latouche C, Jowett JB, Carey AL, Bertovic DA, Owen N, Dunstan DW, Kingwell BA. Effects of breaking up prolonged sitting on skeletal muscle gene expression. J Appl Physiol 2013;114(4):453-60.
  222. Lee CM, Colagiuri R, Magliano DJ, Cameron AJ, Shaw J, Zimmet P, Colagiuri S. The cost of diabetes in adults in Australia. Diabetes Res Clin Pract 2013;99(3):385-90.
  223. Lee YY, Moujalled D, Doerflinger M, Gangoda L, Weston R, Rahimi A, de Alboran I, Herold M, Bouillet P, Xu Q, Gao X, Du XJ, Puthalakath H. CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis. Cell Death Differ 2013;20(7):941-52.
  224. Lee-Young RS, Bonner JS, Mayes WH, Iwueke I, Barrick BA, Hasenour CM, Kang L, Wasserman DH. AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle. Diabetologia 2013;56(3):608-17.
  225. Li CC, Young PE, Maloney CA, Eaton SA, Cowley MJ, Buckland ME, Preiss T, Henstridge DC, Cooney GJ, Febbraio MA, Martin DI, Cropley JE, Suter CM. Maternal obesity and diabetes induces latent metabolic defects and widespread epigenetic changes in isogenic mice. Epigenetics 2013;8(6):602-11.
  226. Licciardi PV, Ververis K, Tang ML, El-Osta A, Karagiannis TC. Immunomodulatory effects of histone deacetylase inhibitors. Curr Mol Med 2013;13(4):640-7. Review.
  227. Lim HS, Stub D, Ajani AE, Andrianopoulos N, Reid CM, Charter K, Black A, Smith K, New G, Chan W, Lim CC, Farouque O, Shaw J, Brennan A, Duffy SJ, Clark DJ. Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary intervention. Int J Cardiol 2013;166(2):425-30.
  228. Lim HS, Willoughby SR, Schultz C, Gan C, Alasady M, Lau DH, Leong DP, Brooks AG, Young GD, Kistler PM, Kalman JM, Worthley MI, Sanders P. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol 2013;61(8):852-60.
  229. Lim K, Burke SL, Head GA. Obesity-related hypertension and the role of insulin and leptin in high-fat-fed rabbits. Hypertension 2013;61(3):628-34.
  230. Lindegaard B, Matthews VB, Brandt C, Hojman P, Allen TL, Estevez E, Watt MJ, Bruce CR, Mortensen OH, Syberg S, Rudnicka C, Abildgaard J, Pilegaard H, Hidalgo J, Ditlevsen S, Alsted TJ, Madsen AN, Pedersen BK, Febbraio MA. Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice. Diabetes 2013;62(9):3064-74.
  231. Linderborg KM, Kaur G, Miller E, Meikle PJ, Larsen AE, Weir JM, Nuora A, Barlow CK, Kallio HP, Cameron-Smith D, Sinclair AJ. Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in humans. Prostaglandins Leukot Essent Fatty Acids 2013;88(4):313-9.
  232. Ling LH, Kalman JM, Ellims AH, Iles LM, Medi C, Sherratt C, Kaye DM, Hare JL, Kistler PM, Taylor AJ. Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation. Circ Arrhythm Electrophysiol 2013;6(4):697-704.
  233. Ling LH, Taylor AJ, Ellims AH, Iles LM, McLellan AJ, Lee G, Kumar S, Lee G, Teh A, Medi C, Kaye DM, Kalman JM, Kistler PM. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm 2013;10(9):1334-9.
  234. Lithovius R, Harjutsalo V, Saraheimo M, Forsblom C, Groop PH; FinnDiane Study Group. Longitudinal trends in use and costs of prescription medication in patients with type 1 diabetes: the impact of renal disease. Ann Med 2013;45(2):112-9.
  235. Little PJ, Osman N, Cohen N. Understanding diabetes and its complications for biomedical research. Int J Diabetol Vasc Dis Res 2013;1(4):401. Editorial.
  236. Liu B, Roberts CL, Clarke M, Jorm L, Hunt J, Ward J. Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sex Transm Infect 2013;89(8):672-8.
  237. Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W. Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment. Vasc Health Risk Manag 2013;9:21-8.
  238. Luke JN, Brown A, Daniel M, O'Dea K, Best JD, Jenkins AJ, Wang Z, McDermott RA, Wang Z, Rowley KG. The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Res Clin Pract 2013;100(3):e70-3.
  239. Lumsden NG, Andrews KL, Bobadilla M, Moore XL, Sampson AK, Shaw JA, Mizrahi J, Kaye DM, Dart AM, Chin-Dusting JP. Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome. Diab Vasc Dis Res 2013;10(4):368-74.
  240. Lunke S, El-Osta A. Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy. Neurotherapeutics 2013;10(4):677-87. Review.
  241. Luo Y, Wang YL, Wu YB, Xu Y, Head GA, Barry M, Liang YL. Association between the rate of the morning surge in blood pressure and cardiovascular events and stroke. Chin Med J 2013;126(3):510-4.
  242. Lynch BM, Courneya KS, Friedenreich CM. A case-control study of lifetime occupational sitting and likelihood of breast cancer. Cancer Causes Control 2013;24(6):1257-62.
  243. Lynch BM, Dunstan DW, Vallance JK, Owen N. Don't take cancer sitting down: a new survivorship research agenda. Cancer 2013;119(11):1928-35. Comment.
  244. Lyons JG, Stewart S. Commentary: tuberculosis, diabetes and smoking: a burden greater than the sum of its parts. Int J Epidemiol 2013;42(1):230-2. Comment.
  245. Mabry RM, Winkler EA, Reeves MM, Eakin EG, Owen N. Correlates of Omani adults' physical inactivity and sitting time. Public Health Nutr 2013;16(1):65-72.
  246. Magliano DJ, Lyons JG. Bisphenol A and diabetes, insulin resistance, cardiovascular disease and obesity: controversy in a (plastic) cup? J Clin Endocrinol Metab 2013;98(2):502-4. Comment.
  247. Maguire G. Bronchiectasis--reply. Aust Fam Physician 2013;42(3):89. Author reply.
  248. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 2013;128(2):132-40.
  249. Makena Hightower C, Zhang K, Miramontes-González JP, Rao F, Wei Z, Schork AJ, Nievergelt CM, Biswas N, Mahata M, Eikelis N, Taupenot L, Stridsberg M, Ziegler MG, O'Connor DT. Genetic variation at the delta-sarcoglycan (SGCD) locus elevates heritable sympathetic nerve activity in human twin pairs. J Neurochem 2013;127(6):750-61.
  250. Mäkinen VP, Kangas AJ, Soininen P, Würtz P, Groop PH, Ala-Korpela M. Metabolic phenotyping of diabetic nephropathy. Clin Pharmacol Ther 2013;94(5):566-9. Review.
  251. Mäkinen VP, Soininen P, Kangas AJ, Forsblom C, Tolonen N, Thorn LM, Viikari J, Raitakari OT, Savolainen M, Groop PH, Ala-Korpela M; Finnish Diabetic Nephropathy Study Group. Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study. J Intern Med 2013;273(4):383-95.
  252. Malan L, Hamer M, Schlaich MP, Lambert G, Ziemssen T, Reimann M, Frasure-Smith N, Amirkhan JH, Schutte R, van Rooyen JM, Mels CM, Fourie CM, Uys AS, Malan NT. Defensive coping facilitates higher blood pressure and early sub-clinical structural vascular disease via alterations in heart rate variability: the SABPA study. Atherosclerosis 2013;227(2):391-7.
  253. Malan L, Hamer M, Schlaich MP, Lambert GW, Ziemssen T, Reimann M, Steyn HS, Schutte R, Smith W, van Rooyen JM, Fourie CM, Malan NT. Defensive active coping facilitates chronic hyperglycaemia and endothelial dysfunction in African men: the SABPA study. Int J Cardiol 2013;168(2):999-1005.
  254. Man K, Miasari M, Shi W, Xin A, Henstridge DC, Preston S, Pellegrini M, Belz GT, Smyth GK, Febbraio MA, Nutt SL, Kallies A. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat Immunol 2013;14(11):1155-65.
  255. Mannan HR, Stevenson CE, Peeters A, McNeil JJ. A new set of risk equations for predicting long term risk of all-cause mortality using cardiovascular risk factors. Prev Med 2013;56(1):41-5.
  256. Maple-Brown LJ, Brown A, Lee IL, Connors C, Oats J, McIntyre HD, Whitbread C, Moore E, Longmore D, Dent G, Corpus S, Kirkwood M, Svenson S, van Dokkum P, Chitturi S, Thomas S, Eades S, Stone M, Harris M, Inglis C, Dempsey K, Dowden M, Lynch M, Boyle J, Sayers S, Shaw J, Zimmet P, O Dea K. Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) study. BMC Pregnancy Childbirth 2013;13(1):221. Protocol.
  257. Martin CA, Cameron JD, Head GA, Chen SS, Eikelis N, McGrath BP. The morning blood pressure surge is related to serum cholesterol. J Hum Hypertens 2013;27(5):315-20.
  258. Matsumoto A, Manthey HD, Marsh SA, Fassett RG, de Haan JB, Rolfe BE, Coombes JS. Effects of exercise training and RhoA/ROCK inhibition on plaque in ApoE(-/-) mice. Int J Cardiol 2013;167(4):1282-8.
  259. Maxwell SS, Pelka GJ, Tam PP, El-Osta A. Chromatin context and ncRNA highlight targets of MeCP2 in brain. RNA Biol 2013;10(11):1741-59.
  260. McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Stewart S, Krum H. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF). Int J Cardiol 2013;169(2):133-8.
  261. McLellan AJ, Kistler PM. Periesophageal vagal nerve injury post-AF ablation: the esophagus a vulnerable neighbor? J Cardiovasc Electrophysiol 2013;24(8):852-4. Editorial.
  262. McLellan AJ, Kumar S, Smith C, Morton JB, Kalman JM, Kistler PM. The role of adenosine following pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a systematic review. J Cardiovasc Electrophysiol 2013;24(7):742-51. Systematic review.
  263. McLellan AJ, Schlaich MP. Dabigatran elimination: is haemodialysis effective? Thromb Haemost 2013;109(4):580-1. Editorial.
  264. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity 2013;21 Suppl 1:S1-S27. Surg Obes Relat Dis 2013;9(2):159-91. Endocr Pract 2013;19(2):337-72. Guidelines.
  265. Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, Kistler P, Kalman J. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol 2013;62(6):531-9.
  266. Medley TL, Furtado M, Lam NT, Idrizi R, Williams D, Verma PJ, Costa M, Kaye DM. Effect of oxygen on cardiac differentiation in mouse iPS cells: role of hypoxia inducible factor-1 and Wnt/beta-catenin signaling. PLoS One 2013;8(11):e80280.
  267. Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, Macintosh GL, Almasy L, Comuzzie AG, Mahaney MC, Kowalczyk A, Haviv I, Grantham N, Magliano DJ, Jowett JB, Zimmet P, Curran JE, Blangero J, Shaw J. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 2013;8(9):e74341.
  268. Mellor KM, Bell JR, Ritchie RH, Delbridge LM. Myocardial insulin resistance, metabolic stress and autophagy in diabetes. Clin Exp Pharmacol Physiol 2013;40(1):56-61. Review.
  269. Meng S, Cao J, Zhang X, Fan Y, Fang L, Wang C, Lv Z, Fu D, Li Y. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One 2013;8(7):e68611.
  270. Miller CT, Fraser SF, Levinger I, Straznicky NE, Dixon JB, Reynolds J, Selig SE. The effects of exercise training in addition to energy restriction on functional capacities and body composition in obese adults during weight loss: a systematic review. PLoS One 2013;8(11):e81692. Systematic review.
  271. Miller CT, Fraser S, Straznicky N, Dixon JB, Selig S, Levinger I. Effect of diet versus diet and exercise on weight loss and body composition in class II and III obesity: a systematic review. J Diabetes Metab 2013;4(6):281. Systematic review.
  272. Minges KE, Magliano DJ, Owen N, Daly RM, Salmon J, Shaw JE, Zimmet PZ, Dunstan DW. Associations of strength training with impaired glucose metabolism: the AusDiab study. Med Sci Sports Exerc 2013;45(2):299-303.
  273. Mittag D, Varese N, Scholzen A, Mansell A, Barker G, Rice G, Rolland JM, O'Hehir RE. TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells. Eur J Immunol 2013;43(3):723-33.
  274. Miura S, Kai Y, Tadaishi M, Tokutake Y, Sakamoto K, Bruce CR, Febbraio MA, Kita K, Chohnan S, Ezaki O. Marked phenotypic differences of endurance performance and exercise-induced oxygen consumption between AMPK and LKB1 deficiency in mouse skeletal muscle: changes occurring in the diaphragm. Am J Physiol Endocrinol Metab 2013;305(2):E213-29.
  275. Moe KT, Naylynn TM, Yin NO, Khairunnisa K, Allen JC, Wong MC, Chin-Dusting J, Wong P. Tumor necrosis factor-α induces aortic intima-media thickening via perivascular adipose tissue inflammation. J Vasc Res 2013;50(3):228-37.
  276. Moore XL, Michell D, Lee S, Skilton MR, Nair R, Dixon JB, Dart AM, Chin-Dusting J. Increased carotid intima-media thickness and reduced distensibility in human class III obesity: independent and differential influences of adiposity and blood pressure on the vasculature. PLoS One 2013;8(1):e53972.
  277. Morton J, Ng MK, Chalmers J, Woodward M, Mancia G, Poulter NR, Marre M, Cooper ME, Zoungas S; for the ADVANCE collaborative group. The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality? Cancer Epidemiol Biomarkers Prev 2013;22(9):1628-33.
  278. Murphy AJ. High density lipoprotein: assembly, structure, cargo and functions. ISRN Physiol 2013;2013:186365. Review.
  279. Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, Wang Y, Shaw JA, Levine RL, Ni H, Tall AR, Wang N. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med 2013;19(5):586-94.
  280. Murphy AJ, Hoang A, Aprico A, Sviridov D, Chin-Dusting J. Anti-inflammatory functions of apolipoprotein a-I and high-density lipoprotein are preserved in trimeric apolipoprotein a-I. J Pharmacol Exp Ther 2013;344(1):41-9.
  281. Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease. Arterioscler Thromb Vasc Biol 2013;33(12):2902-8.
  282. Nestel PJ, Mellett N, Pally S, Wong G, Barlow CK, Croft K, Mori TA, Meikle PJ. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br J Nutr 2013;110(12):2242-9.
  283. Nestel PJ, Mensink RP. Perspective: nonalcoholic fatty liver disease and cardiovascular risk. Curr Opin Lipidol 2013;24(1):1-3. Editorial.
  284. Neubauer O, Sabapathy S, Lazarus R, Jowett JB, Desbrow B, Peake JM, Cameron-Smith D, Haseler LJ, Wagner KH, Bulmer AC. Transcriptome analysis of neutrophils after endurance exercise reveals novel signaling mechanisms in the immune response to physiological stress. J Appl Physiol 2013;114(12):1677-88.
  285. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitorin. J Hypertens 2013;31(9):1731-68. Guidelines.
  286. O'Hara BJ, Bauman AE, Eakin EG, King L, Haas M, Allman-Farinelli M, Owen N, Cardona-Morell M, Farrell L, Milat AJ, Phongsavan P. Evaluation framework for translational research: case study of Australia's Get Healthy Information and Coaching Service®. Health Promot Pract 2013;14(3):380-9.
  287. Ojji D, Stewart S, Ajayi S, Manmak M, Sliwa K. A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases. Eur J Heart Fail 2013;15(8):835-42.
  288. Olsson LG, Swedberg K, Lappas G, Stewart S, Rosengren A. Trends in mortality after first hospitalization with atrial fibrillation diagnosis in Sweden 1987 to 2006. Int J Cardiol 2013;170(1):75-80.
  289. Olsson LG, Swedberg K, Lappas G, Stewart S, Rosengren A. Trends in stroke incidence after hospitalization for atrial fibrillation in Sweden 1987 to 2006. Int J Cardiol 2013;167(3):733-8.
  290. Osman N, Grande-Allen KJ, Ballinger ML, Getachew R, Marasco S, O'Brien KD, Little PJ. Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycans. Cardiovasc Pathol 2013;22(2):146-55.
  291. Panduru NM, Forsblom C, Saraheimo M, Thorn L, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group. Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 2013;36(7):2077-83.
  292. Paul CL, Piterman L, Shaw J, Kirby C, Sanson-Fisher RW, Carey ML, Robinson J, McElduff P, Thepwongsa I. Diabetes in rural towns: effectiveness of continuing education and feedback for healthcare providers in altering diabetes outcomes at a population level: protocol for a cluster randomised controlled trial. Implement Sci 2013;8:30. Protocol.
  293. Peeters A. Comment on: Does bariatric surgery reduce the risk of major cardiovascular events? A retrospective cohort study of morbidly obese surgical patients. Surg Obes Relat Dis 2013;9(1):39-41. Comment.
  294. Peräneva L, Fogarty CL, Pussinen PJ, Forsblom C, Groop PH, Lehto M. Systemic exposure to Pseudomonal bacteria: a potential link between type 1 diabetes and chronic inflammation. Acta Diabetol 2013;50(3):351-61.
  295. Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, Macmahon S, Cooper ME, Hamet P, Marre M, Mogensen CE, Poulter N, Mancia G, Cass A, Patel A, Zoungas S. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int 2013;83(3):517-23.
  296. Peter K. Isoform-specific effects of protein phosphatase 1 on outside-in signalling of integrin αIIbβ3: a story told by genetic manipulation of platelet surrogate cells. Thromb Haemost 2013;109(1):7. Editorial.
  297. Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bügel S, Nielsen J, Skibsted LH, Dragsted LO. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol 2013;60:10-37. Review.
  298. Prabhu S, McLellan AJ, Voskoboinik A, Kistler PM. Novel uses of imaging in AF ablation. Recent Pat Cardiovasc Drug Discov 2013;8(2):93-111. Review.
  299. Qin C, Buxton KD, Pepe S, Cao AH, Venardos K, Love JE, Kaye DM, Yang YH, Morand EF, Ritchie RH. Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A12-26. Br J Pharmacol 2013;168(1):238-52.
  300. Rae K, Weatherall L, Hollebone K, Apen K, McLean M, Blackwell C, Eades S, Boulton J, Lumbers E, Smith R. Developing research in partnership with Aboriginal communities - strategies for improving recruitment and retention. Rural Remote Health 2013;13(2):2255. Comment.
  301. Rahimi F, Goire N, Guy R, Kaldor JM, Ward J, Nissen MD, Sloots TP, Whiley DM. Direct urine polymerase chain reaction for chlamydia and gonorrhoea: a simple means of bringing high-throughput rapid testing to remote settings? Sex Health 2013;10(4):299-304.
  302. Rajapakse NW, Chong AL, Zhang WZ, Kaye DM. Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetes. PLoS One 2013;8(5):e61840.
  303. Rajapakse NW, Mattson DL. Role of cellular L-arginine uptake and nitric oxide production on renal blood flow and arterial pressure regulation. Curr Opin Nephrol Hypertens 2013;22(1):45-50. Review.
  304. Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire GP, Kelly PM, Anstey NM. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One 2013;8(11):e80302.
  305. Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, Sandjaja, Lolong DB, Yeo TW, Chatfield MD, Soemanto RK, Bastian I, Lumb R, Maguire GP, Eisman J, Price RN, Morris PS, Kelly PM, Anstey NM. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One 2013;8(8):e70032.
  306. Ralph AP, Yeo TW, Salome CM, Waramori G, Pontororing GJ, Kenangalem E, Sandjaja, Tjitra E, Lumb R, Maguire GP, Price RN, Chatfield MD, Kelly PM, Anstey NM. Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment. J Infect Dis 2013;208(4):616-26.
  307. Randall DA, Jorm LR, Lujic S, O'Loughlin AJ, Eades SJ, Leyland AH. Disparities in revascularization rates after acute myocardial infarction between Aboriginal and non-Aboriginal people in Australia. Circulation 2013;127(7):811-9.
  308. Rasmiena AA, Ng TW, Meikle PJ. Metabolomics and ischaemic heart disease. Clin Sci 2013;124(5):289-306. Review.
  309. Reeves MM, Healy GN, Owen N, Shaw JE, Zimmet PZ, Dunstan DW. Joint associations of poor diet quality and prolonged television viewing time with abnormal glucose metabolism in Australian men and women. Prev Med 2013;57(5):471-6.
  310. Reid N, Eakin E, Henwood T, Keogh JW, Senior HE, Gardiner PA, Winkler E, Healy GN. Objectively measured activity patterns among adults in residential aged care. Int J Environ Res Public Health 2013;10(12):6783-98.
  311. Reimann M, Hamer M, Malan NT, Schlaich MP, Lambert GW, Ziemssen T, Boeger RH, Malan L. Effects of acute and chronic stress on the L-arginine nitric oxide pathway in black and white South Africans: the Sympathetic Activity and Ambulatory Blood Pressure in Africans Study. Psychosom Med 2013;75(8):751-8.
  312. Rémond MG, Severin KL, Hodder Y, Martin J, Nelson C, Atkinson D, Maguire GP. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia. Intern Med J 2013;43(4):386-93.
  313. Rémond MG, Wark EK, Maguire GP. Screening for rheumatic heart disease in Aboriginal and Torres Strait Islander children. J Paediatr Child Health 2013;49(7):526-31. Review.
  314. Reutens AT. Epidemiology of diabetic kidney disease. Med Clin N Am 2013;97(1):1-18. Review.
  315. Reutens AT, Bonnet F, Lantieri O, Roussel R, Balkau B; Data from an Epidemiological Study on the Insulin Resistance Syndrome Study Group. The association between cystatin C and incident type 2 diabetes is related to central adiposity. Nephrol Dial Transplant 2013;28(7):1820-9.
  316. Ritchie RH, Leo CH, Qin C, Stephenson EJ, Bowden MA, Buxton KD, Lessard SJ, Rivas DA, Koch LG, Britton SL, Hawley JA, Woodman OL. Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function. Am J Physiol Heart Circ Physiol 2013;304(5):H729-39.
  317. Roberts KV, Brown AD, Maguire GP, Atkinson DN, Carapetis JR. Utility of auscultatory screening for detecting rheumatic heart disease in high-risk children in Australia's Northern Territory. Med J Aust 2013;199(3):196-9.
  318. Rose H, Low H, Dewar E, Bukrinsky M, Hoy J, Dart A, Sviridov D. The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study. Atherosclerosis 2013;229(1):206-11.
  319. Rosenfeldt F, Wilson M, Lee G, Kure C, Ou R, Braun L, de Haan J. Oxidative stress in surgery in an ageing population: pathophysiology and therapy. Exp Gerontol 2013;48(1):45-54. Review.
  320. Royce SG, Lim C, Muljadi RC, Samuel CS, Ververis K, Karagiannis TC, Giraud AS, Tang ML. Trefoil factor-2 reverses airway remodeling changes in allergic airways disease. Am J Respir Cell Mol Biol 2013;48(1):135-44.
  321. Ruta LM, Magliano DJ, Lemesurier R, Taylor HR, Zimmet PZ, Shaw JE. Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med 2013;30(4):387-98. Systematic review.
  322. Sacre JW, Jellis CL, Coombes JS, Marwick TH. Reply to Morton. Heart-rate responses to exercise in patients with diabetes with acute or chronic autonomic dysfunction. Diabet Med 2013;30(8):1010-1. Author reply.
  323. Salinari S, Debard C, Bertuzzi A, Durand C, Zimmet P, Vidal H, Mingrone G. Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance. PLoS One 2013;8(2):e56258.
  324. Sandholm N, McKnight AJ, Salem RM, Brennan EP, Forsblom C, Harjutsalo V, Mäkinen VP, McKay GJ, Sadlier DM, Williams WW, Martin F, Panduru NM, Tarnow L, Tuomilehto J, Tryggvason K, Zerbini G, Comeau ME, Langefeld CD; FIND Consortium, Godson C, Hirschhorn JN, Maxwell AP, Florez JC, Groop PH; FinnDiane Study Group and the GENIE Consortium. Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. J Am Soc Nephrol 2013;24(10):1537-43.
  325. Sata Y, Xu J, Hering D, Schlaich M. Treating resistant hypertension now and in the future. Med Today 2013;14(1):20-7. Review.
  326. Sathish T, Williams ED, Pasricha N, Absetz P, Lorgelly P, Wolfe R, Mathews E, Aziz Z, Thankappan KR, Zimmet P, Fisher E, Tapp R, Hollingsworth B, Mahal A, Shaw J, Jolley D, Daivadanam M, Oldenburg B. Cluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala diabetes prevention program. BMC Public Health 2013;13(1):1035. Protocol.
  327. Schlaich M, Hering D, Lambert G, Lambert E, Esler M. Blood pressure and sympathetic nervous system response to renal denervation. Hypertension 2013;61(2):e13. Letter.
  328. Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol 2013;168(3):2214-20.
  329. Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsioufis C, Vonend O, Weber MA, Williams B, Zeller T, Esler MD. International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol 2013;62(22):2031-45. Statement.
  330. Schwartz CE, Lambert E, Medow MS, Stewart JM. Disruption of phase synchronization between blood pressure and muscle sympathetic nerve activity in postural vasovagal syncope. Am J Physiol Heart Circ Physiol 2013;305(8):H1238-45.
  331. Secombe PJ, Brown A, Kruger PS, Stewart PC. Lipid profiles and persisting inflammation following critical illness in a Central Australian population: a prospective longitudinal observational study. Intern Med J 2013;43(4):445-9.
  332. Sedeek M, Gutsol A, Montezano AC, Burger D, Nguyen Dinh Cat A, Kennedy CR, Burns KD, Cooper ME, Jandeleit-Dahm K, Page P, Szyndralewiez C, Heitz F, Hebert RL, Touyz RM. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes. Clin Sci 2013;124(3):191-202.
  333. Seto JT, Quinlan KG, Lek M, Zheng XF, Garton F, MacArthur DG, Hogarth MW, Houweling PJ, Gregorevic P, Turner N, Cooney GJ, Yang N, North KN. ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling. J Clin Invest 2013;123(10):4255-63.
  334. Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, Pu M, Sharma S, You YH, Wang L, Diamond-Stanic M, Lindenmeyer MT, Forsblom C, Wu W, Ix JH, Ideker T, Kopp JB, Nigam SK, Cohen CD, Groop PH, Barshop BA, Natarajan L, Nyhan WL, Naviaux RK. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 2013;24(11):1901-12.
  335. Shetty SV, Roberts TJ, Schlaich MP. Percutaneous transluminal renal denervation: a potential treatment option for polycystic kidney disease-related pain? Int J Cardiol 2013;162(3):e58-9. Letter.
  336. Shmela ME, Gicquel CF. Human diseases versus mouse models: insights into the regulation of genomic imprinting at the human 11p15/mouse distal chromosome 7 region. J Med Genet 2013;50(1):11-20. Review.
  337. Shortreed SM, Peeters A, Forbes AB. Estimating the effect of long-term physical activity on cardiovascular disease and mortality: evidence from the Framingham Heart study. Heart 2013;99(9):649-54.
  338. Siebel AL, Natoli AK, Yap FY, Carey AL, Reddy-Luthmoodoo M, Sviridov D, Weber CI, Meneses-Lorente G, Maugeais C, Forbes JM, Kingwell BA. Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion. Circ Res 2013;113(2):167-75.
  339. Silbernagel G, Genser B, Nestel P, März W. Plant sterols and atherosclerosis. Curr Opin Lipidol 2013;24(1):12-7. Review.
  340. Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis 2013;61(2):238-46.
  341. Skoien R, Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, O'Brien PE, Tilg H, Moschen AR, Baumann U, Brown RM, Couper RT, Manton ND, Ee LC, Weltman M, Clouston AD. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Liver Int 2013;33(4):624-32.
  342. Sliwa K, Lee GA, Carrington MJ, Obel P, Okreglicki A, Stewart S. Redefining the ECG in urban South Africans: electrocardiographic findings in heart disease-free Africans. Int J Cardiol 2013;167(5):2204-9.
  343. Song X, Jousilahti P, Stehouwer CD, Söderberg S, Onat A, Laatikainen T, Yudkin JS, Dankner R, Morris R, Tuomilehto J, Qiao Q. Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr 2013;67(12):1298-302.
  344. Sorich MJ, Coory M, Pekarsky BA. Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups. PLoS One 2013;8(8):e72256.
  345. Sorich MJ, Horowitz JD, Sorich W, Wiese MD, Pekarsky B, Karnon JD. Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia. Pharmacogenomics 2013;14(16):2013-21.
  346. Sorich MJ, Wiese MD, O'Shea RL, Pekarsky B. Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia. Pharmacoeconomics 2013;31(5):377-91. Review.
  347. Srikanth V, Westcott B, Forbes J, Phan TG, Beare R, Venn A, Pearson S, Greenaway T, Parameswaran V, Münch G. Methylglyoxal, cognitive function and cerebral atrophy in older people. J Gerontol A Biol Sci Med Sci 2013;68(1):68-73.
  348. Stephenson DT, Jandeleit-Dahm K, Balkau B, Cohen N. Improvement in albuminuria in patients with type 2 diabetes after laparoscopic adjustable gastric banding. Diab Vasc Dis Res 2013;10(6):514-9.
  349. Stewart S. What is the optimal place for heart failure treatment and care: home or hospital? Curr Heart Fail Rep 2013;10(3):227-31. Review.
  350. Stewart S, Carrington MJ, Swemmer CH, Kurstjens NP, Brown A, Burrell LM, Nelson M, Stocks NP, Jennings GL; VIPER-BP Study Investigators. Determinants of achieving early blood pressure control with monotherapy in a primary care setting. J Clin Hypertens 2013;15(9):674-80.
  351. Strange G, Gabbay E, Kermeen F, Williams T, Carrington M, Stewart S, Keogh A. Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: the DELAY Study. Pulm Circ 2013;3(1):89-94.
  352. Straznicky NE, Grima MT, Sari CI, Karapanagiotidis S, Wong C, Eikelis N, Richards KL, Lee G, Nestel PJ, Dixon JB, Lambert GW, Schlaich MP, Lambert EA. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome. J Clin Endocrinol Metab 2013;98(2):E227-37.
  353. Straznicky NE, Lambert EA, Lambert GW. Response to Comment on: Straznicky et al. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516. Diabetes 2013;62(1):e2. Author reply.
  354. Stub D, Byrne M, Pellegrino V, Kaye DM. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in a sheep model of refractory ischaemic cardiac arrest. Heart Lung Circ 2013;22(6):421-7.
  355. Sugiyama T, Ding D, Owen N. Commuting by car: weight gain among physically active adults. Am J Prev Med 2013;44(2):169-73.
  356. Sugiyama T, Giles-Corti B, Summers J, du Toit L, Leslie E, Owen N. Initiating and maintaining recreational walking: a longitudinal study on the influence of neighborhood green space. Prev Med 2013;57(3):178-82.
  357. Sugiyama T, Owen N, Ding D. Author response. Am J Prev Med 2013;45(1):e2. Author reply.
  358. Sviridov D. Many ABCs make light work with cholesterol. Aging 2013;5(9):637-8. Editorial.
  359. Takamiya Y, Fukami K, Yamagishi S, Kaida Y, Nakayama Y, Obara N, Iwatani R, Ando R, Koike K, Matsui T, Nishino Y, Ueda S, Cooper ME, Okuda S. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice. Nephrol Dial Transplant 2013;28(1):55-62.
  360. Tan SM, Sharma A, Yuen DY, Stefanovic N, Krippner G, Mugesh G, Chai Z, de Haan JB. The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice. PLoS One 2013;8(7):e69193.
  361. Tan SM, Stefanovic N, Tan G, Wilkinson-Berka JL, de Haan JB. Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice. Invest Ophthalmol Vis Sci 2013;54(1):555-62.
  362. Tanamas SK, Wluka AE, Davies-Tuck M, Wang Y, Strauss BJ, Proietto J, Dixon JB, Jones G, Forbes A, Cicuttini FM. Association of weight gain with incident knee pain, stiffness, and functional difficulties: a longitudinal study. Arthritis Care Res 2013;65(1):34-43.
  363. Taylor AJ, Ellims A, Lew PJ, Murphy B, Pally S, Younie S. Impact of cardiac magnetic resonance imaging on cardiac device and surgical therapy: a prospective study. Int J Cardiovasc Imaging 2013;29(4):855-64.
  364. Thallas-Bonke V, Cooper ME. Tandem inhibition of PKC in diαβetic nephropathy: it takes two to tango? Diabetes 2013;62(4):1010-1. Comment.
  365. Thallas-Bonke V, Coughlan MT, Tan AL, Harcourt BE, Morgan PE, Davies MJ, Bach LA, Cooper ME, Forbes JM. Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content. Nephrology 2013;18(1):47-56.
  366. Thomas MC. Emerging drugs for managing kidney disease in patients with diabetes. Expert Opin Emerg Drugs 2013;18(1):55-70. Review.
  367. Thomas MC, Groop PH. Assessing renal risk in patients with type 2 diabetes. Nat Rev Nephrol 2013;9(10):559-60. Comment.
  368. Thorp AA, Larsen RN, Schlaich MP. Renal sympathetic nerve ablation for the management of resistant hypertension: an update. Curr Opin Nephrol Hypertens 2013;22(6):607-14. Review.
  369. Thorp AA, McNaughton SA, Owen N, Dunstan DW. Independent and joint associations of TV viewing time and snack food consumption with the metabolic syndrome and its components; a cross-sectional study in Australian adults. Int J Behav Nutr Phys Act 2013;10(1):96.
  370. Tikellis C, Pickering RJ, Tsorotes D, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Forsblom C, Groop PH, Cooper ME, Moran J, Thomas MC. Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with type 1 diabetes. Clin Sci 2013;124(10):617-26.
  371. Toelle BG, Xuan W, Bird TE, Abramson MJ, Atkinson DN, Burton DL, James AL, Jenkins CR, Johns DP, Maguire GP, Musk AW, Walters EH, Wood-Baker R, Hunter ML, Graham BJ, Southwell PJ, Vollmer WM, Buist AS, Marks GB. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust 2013;198(3):144-8.
  372. Toh BH, Kyaw T, Tipping P, Bobik A. Immune regulation by CD52-expressing CD4 T cells. Cell Mol Immunol 2013;10(5):379-82. Review.
  373. Tolonen N, Hietala K, Forsblom C, Harjutsalo V, Mäkinen VP, Kytö J, Summanen PA, Thorn LM, Wadén J, Gordin D, Taskinen MR, Groop PH; FinnDiane Study Group. Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study. J Intern Med 2013; 274(5):469-79.
  374. Tomabechi Y, Krippner G, Rendle PM, Squire MA, Fairbanks AJ. Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists. Chemistry 2013;19(45):15084-8.
  375. Turner N, Kowalski GM, Leslie SJ, Risis S, Yang C, Lee-Young RS, Babb JR, Meikle PJ, Lancaster GI, Henstridge DC, White PJ, Kraegen EW, Marette A, Cooney GJ, Febbraio MA, Bruce CR. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 2013;56(7):1638-48.
  376. Van Dyck D, Cerin E, Conway TL, De Bourdeaudhuij I, Owen N, Kerr J, Cardon G, Frank LD, Saelens BE, Sallis JF. Perceived neighborhood environmental attributes associated with adults' leisure-time physical activity: findings from Belgium, Australia and the USA. Health Place 2013;19:59-68.
  377. van Empel VP, Kaye DM. Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fraction. Int J Cardiol 2013;168(2):716-22. Review.
  378. Ververis K, Hiong A, Karagiannis TC, Licciardi PV. Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents. Biologics 2013;7:47-60. Review.
  379. Ververis K, Karagiannis TC. The potential role of HDAC inhibitors in de-silencing latent HIV virus. Drugs Fut 2013;38(8):575. Review.
  380. Wadley GD, McConell GK, Goodman CA, Siebel AL, Westcott KT, Wlodek ME. Growth restriction in the rat alters expression of metabolic genes during postnatal cardiac development in a sex-specific manner. Physiol Genomics 2013;45(3):99-105.
  381. Wang Y, Tikellis C, Thomas MC, Golledge J. Angiotensin converting enzyme 2 and atherosclerosis. Atherosclerosis 2013;226(1):3-8. Review.
  382. Ward J, McGregor S, Guy RJ, Rumbold AR, Garton L, Silver BJ, Taylor-Thomson D, Hengel B, Knox J, Dyda A, Law MG, Wand H, Donovan B, Fairley CK, Skov S, Ah Chee D, Boffa J, Glance D, McDermott R, Maher L, Kaldor JM. STI in remote communities: improved and enhanced primary health care (STRIVE) study protocol: a cluster randomised controlled trial comparing 'usual practice' STI care to enhanced care in remote primary health care services in Australia. BMC Infect Dis 2013;13:425. Protocol.
  383. Ward MS, Fortheringham AK, Cooper ME, Forbes JM. Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease. Curr Opin Pharmacol 2013;13(4):654-61. Review.
  384. Wark EK, Hodder YC, Woods CE, Maguire GP. Patient and health-care impact of a pilot rheumatic heart disease screening program. J Paediatr Child Health 2013;49(4):297-302.
  385. Watson AM, Olukman M, Koulis C, Tu Y, Samijono D, Yuen D, Lee C, Behm DJ, Cooper ME, Jandeleit-Dahm KA, Calkin AC, Allen TJ. Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. Diabetologia 2013;56(5):1155-65.
  386. Watts R, McAinch AJ, Dixon JB, O'Brien PE, Cameron-Smith D. Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects. Obesity 2013;21(3):525-8.
  387. Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, Comuzzie AG, Mahaney MC, Jowett JB, Shaw J, Curran JE, Blangero J, Meikle PJ. Plasma lipid profiling in a large population-based cohort. J Lipid Res 2013;54(10):2898-908.
  388. Wennberg P, Gustafsson PE, Dunstan DW, Wennberg M, Hammarström A. Television viewing and low leisure-time physical activity in adolescence independently predict the metabolic syndrome in mid-adulthood. Diabetes Care 2013;36(7):2090-7.
  389. Westein E, Flierl U, Hagemeyer CE, Peter K. Destination known: targeted drug delivery in atherosclerosis and thrombosis. Drug Dev Res 2013;74(7):460-71. Review.
  390. Westein E, van der Meer AD, Kuijpers MJ, Frimat JP, van den Berg A, Heemskerk JW. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proc Natl Acad Sci USA 2013;110(4):1357-62.
  391. White AJ, Arasaratnam D, Elliott DA, Kaye DM. Cellular reprogramming: a new avenue to cardiac regeneration? Circ Heart Fail 2013;6(5):1102-7. Review.
  392. White DA, Fang L, Chan W, Morand EF, Kiriazis H, Duffy SJ, Taylor AJ, Dart AM, Du XJ, Gao XM. Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells. PLoS One 2013;8(10):e76206.
  393. White HD, Simes J, Stewart RA, Blankenberg S, Barnes EH, Marschner IC, Thompson P, West M, Zeller T, Colquhoun DM, Nestel P, Keech AC, Sullivan DR, Hunt D, Tonkin A; LIPID Study Investigators. Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-term Intervention with Pravastatin in Ischemic Disease study. J Am Heart Assoc 2013;2(5):e000360.
  394. Whitty JA, Stewart S, Carrington MJ, Calderone A, Marwick T, Horowitz JD, Krum H, Davidson PM, Macdonald PS, Reid C, Scuffham PA. Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the WHICH? trial. PLoS One 2013;8(3):e58347.
  395. Williams ED, Magliano DJ, Tapp RJ, Oldenburg BF, Shaw JE. Psychosocial stress predicts abnormal glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Ann Behav Med 2013;46(1):62-72.
  396. Winbanks CE, Beyer C, Hagg A, Qian H, Sepulveda PV, Gregorevic P. miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4. PLoS One 2013;8(9):e73589.
  397. Winbanks CE, Chen JL, Qian H, Liu Y, Bernardo BC, Beyer C, Watt KI, Thomson RE, Connor T, Turner BJ, McMullen JR, Larsson L, McGee SL, Harrison CA, Gregorevic P. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol 2013;203(2):345-57.
  398. Winkler E, Waters L, Eakin E, Fjeldsoe B, Owen N, Reeves M. Is measurement error altered by participation in a physical activity intervention? Med Sci Sports Exerc 2013;45(5):1004-11.
  399. Woinarski NC, Suzuki S, Lipcsey M, Lumsden N, Chin-Dusting J, Schneider AG, Bailey M, Bellomo R. Near-infrared spectroscopy of the thenar eminence to estimate forearm blood flow. Crit Care Resusc 2013;15(4):323-6.
  400. Wong A, Grubb DR, Cooley N, Luo J, Woodcock EA. Regulation of autophagy in cardiomyocytes by Ins(1,4,5)P3 and IP3-receptors. J Mol Cell Cardiol 2013;54:19-24.
  401. Wong E, Backholer K, Gearon E, Harding J, Freak-Poli R, Stevenson C, Peeters A. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2013;1(2):106-14. Systematic review.
  402. Wong G, Barlow CK, Weir JM, Jowett JB, Magliano DJ, Zimmet P, Shaw J, Meikle PJ. Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes. PLoS One 2013;8(10):e76577.
  403. Wong MC, Kalman JM, Ling LH, Medi C, Teh A, Lee G, Kumar S, Morton JB, Kistler PM. Left septal atrial tachycardias: electrocardiographic and electrophysiologic characterization of a paraseptal focus. J Cardiovasc Electrophysiol 2013;24(4):413-8.
  404. Wong MG, Perkovic V, Woodward M, Chalmers J, Li Q, Hillis GS, Yaghobian Azari D, Jun M, Poulter N, Hamet P, Williams B, Neal B, Mancia G, Cooper M, Pollock CA. Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney Int 2013;83(2):278-84.
  405. Wycherley TP, Buckley JD, Noakes M, Clifton PM, Brinkworth GD. Comparison of the effects of weight loss from a high-protein versus standard-protein energy-restricted diet on strength and aerobic capacity in overweight and obese men. Eur J Nutr 2013;52(1):317-25.
  406. You YH, Okada S, Ly S, Jandeleit-Dahm K, Barit D, Namikoshi T, Sharma K. Role of Nox2 in diabetic kidney disease. Am J Physiol Renal Physiol 2013;304(7):F840-8.
  407. Ziemann M, Kamboj A, Bhave M. OrthoRBH: a streamlined pipeline for mining large gene family sequences in related species. Bioinformation 2013;9(5):267-9.
  408. Ziemann M, Kamboj A, Hove RM, Loveridge S, El-Osta A, Bhave M. Analysis of the barley leaf transcriptome under salinity stress using mRNA-Seq. Acta Physiol Plant 2013;35(6):1915-24.
  409. Ziemann M, Kaspi A, Lazarus R, El-Osta A. Motif analysis in DNAse hypersensitivity regions uncovers distal cis elements associated with gene expression. Bioinformation 2013;9(4):212-5.
  410. Zimmet PZ. Can we avert a diabetes catastrophe in Australia? Med J Aust 2013;199(4):225-6. Editorial.
  411. Zomer E, Owen A, Magliano DJ, Ademi Z, Reid CM, Liew D. Predicting the impact of polypill use in a metabolic syndrome population: an effectiveness and cost-effectiveness analysis. Am J Cardiovasc Drugs 2013;13(2):121-8.
  412. Zurek M, Maeder MT, Brutsche MH, Christ A, Bosshard P, Ziller R, Rickli H, Kaye DM, Mueller C. Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo? Int J Cardiol 2013;167(3):1046-8. Letter.

Books

  1. Knox J, Ward J. STI/BBV Manual: Early Detection and Treatment of Sexually Transmissible Infections and Blood-Borne Viruses, 2nd edition. 2013. Aboriginal Health and Medical Research Council of New South Wales.
  2. Masuo K (ed). Type 2 Diabetes. 2013. ISBN 9789535111719. InTech, Croatia.

Book chapters

  1. Ansari RM, Dixon JB, Browning CJ. Socio-ecological approach to self-management of type 2 diabetes: physical activity and dietary intervention. In: Masuo K (ed), Type 2 Diabetes, InTech, Croatia. 2013. Chapter 15, pp333-51.
  2. Esler MD, Lambert GW. Biochemical investigation of autonomic failure - measurement of catecholamines and metabolites and the use of spillover and allied techniques to determine regional sympathetic activation. In: Mathias CJ, Bannister R (eds), Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System, 5th edition, Oxford University Press, UK. 2013. Chapter 26, pp332-43.
  3. Iyer S, Habersberger J, Vitek J, Brennan C, Roubin G. Carotid artery stenting. In: Creager MA, Beckman JA, Loscalzo J (eds), Vascular Medicine: A Companion to Braunwald's Heart Disease, 2nd edition, Elsevier Saunders, USA. 2013. Chapter 32, pp386-414.
  4. Masuo K. Lifestyle modification is the first line treatment for type 2 diabetes. In: Masuo K (ed), Type 2 Diabetes, InTech, Croatia. 2013. Chapter 16, pp353-83.
  5. Nesbitt WS, Tovar-Lopez FJ, Westein E, Harper IS, Jackson SP. A multimode-TIRFM and microfluidic technique to examine platelet adhesion dynamics. In: Coutts AS (ed), Methods in Molecular Biology, Vol 1046, Adhesion Protein Protocols, 3rd edition. Humana Press, USA. 2013. Chapter 3, pp39-58.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more